U.S. Markets closed

Endocyte, Inc. (ECYT)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.43+0.01 (+0.70%)
At close: 4:00PM EDT
People also watch
INFIACRXMACKEPZMVSTM
  • Relatively low volume but wow 4% down and finished at the days low. The last 12 seconds of trading was someone unloading at 1.41. My guess is the ceo is getting rid of his family's shares. I don't have any other reasonable explanation. Just speclation of course but he sure isn't buying shares.
  • Monster Microcaps Alert to ECYT shareholders. Clean Energy Technologies Moving up now - CETY - price today $.02. Price target $.20 by year end.
    Clean Energy Technologies. CETY recently announced expansion with their Europe Sales and Service Center for Europe new sales and to serve 65 existing customers with CETY’s General Electric clean energy Heat Recovery Systems and just announced they have already sold the first of SEVERAL HUNDRED units to come SOON.

    Each CETY Heat Recovery System sells for $300,000 and market demand is several BILLION DOLLARS.

    CETY purchased Heat Recovery Systems Division from General Electric and products are now very attractive to huge unmet markets and can achieve over $250 million annual sales within the next 2 years. Demand for conversion of wasted heat to electrical energy in big applications is VERY LARGE AND UNMET.

    https://finance.yahoo.com/news/clean-energy-technologies-inc-secures-144700111.html

    Clean Energy Technologies, Inc. Secures New Order for Waste Biomass Application in Europe
    COSTA MESA, Calif., July 12, 2017 /PRNewswire/ -- Clean Energy Technologies, Inc. (CETY) announced today that its subsidiary Heat Recovery Solutions has secured a new Clean CycleTM generator order for a Waste Biomass application in Europe. Growing d
    finance.yahoo.com
  • it's so depressing to see this stock tumble and bleeding day by day...what a bad investment I was stuck in...
  • According to IR, "we are working on a response to give everyone to try and help them understand decisions made as well as path going forward. We should have this finalized by tomorrow".

    Any thoughts on what is going on??? Is this being shorted into oblivion? Who is still unloading shares?
  • Overall I think we will see upside for ECYT in the short-term. Perhaps a pullback next day or so could occur I suppose but are yall also seeing a further leg higher? Do you guys find it difficult to know when to buy or sell something? I prefer to get my stocks from awe*some*stocks.
  • 52 week low today. company really is a pos. negative value after cash. why not sell the company for 3 bucks a share.
  • Endocyte appointed Michael Andriole as Chief Financial Officer back in February. His bio/creds give me the impression he knows the industry well. Seems he would have vetted ECYT and its pipeline well before excepting the position and 50,000 shares as part of his compensation package -- he apparently saw real potential in something -- perhaps CAR-T. The big 40% overhead cut came after he was just a few months on the job and think that he was instrumental in structuring that reduction to help focus resources on the gem(s) he saw. I'm just a novice at this biotech game so my opinion is worth about 10 cents.
  • Very little buying interest. all large blocks are sells. amazing that someone is still unloading huge amount of shares.
  • Did anyone else find today's action absolutely bizarre? I was watching the raw data stream all day; every trade was a sell at 1.51....every 30 minutes a small buy but then sell,sell,sell. I was surprised we didn't go into the 1.4's.

    Was this shorting? My fear is news leaked (of course) and something bad is being released soon. Otherwise what the heck was up with today's price action???
  • usual shenanigans today. went up to 1.70 then faded back to 1.60. wow.
  • People sayo "Think twice before you speak".http://dataunion.tistory.com/10094

    Endocyte NASDAQ $ECYT Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks Sep-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is 0 In other words, the correlation coefficient of the other stocks
    dataunion.tistory.com
  • 5 days without any new posting, I guees everyone jumped ship...
  • it looks like the interest in this stock has totally dried up, even inside this board...I guess management would just try to survive to keep their salary alive...
  • Can any experts share their views on Endocyte's partnership with Seattle Children's Research Institute on developing the next generation CAR T-cell therapeutic platform? Does the latest news impact that opportunity, or is the science distinctively separate?
  • As shareholders we're better off forcing management to liquidate and return the 100 million of cash . Since 1995 they've failed to offer any viable pipeline that can be marketed. 22 years of futility. No reason to believe they'll succeed with the remaining hail-mary pipelines. If your a shareholder send your frustrations to management . Demand accountability and distribution of the 100 million back to shareholders.
  • Next time there is a conference call I think I will pretend to be an analyst, not only so they actually have one caller with a question (LOL...sigh..../cry) but to ask this question:

    Did EC1456 dosing ever exceed the comparable level used in the mouse trials (which I think was 2umol/kg)?

    Will EC2629 begin dosing at its comparable mouse trial level that saw 100% cures (0.3umol/kg)?

    Well that is two questions, but they seem to be fair questions.
  • https://www.ibj.com/blogs/17-the-dose/post/64084-endocytes-surprise-move-stuns-wall-street-raises-questions-about-companys-future?utm_source=ibj-daily&utm_medium=newsletter&utm_campaign=2017-06-07

    The last line of the article says it all...

    Endocyte's surprise move stuns Wall Street, raises questions about company's future
    The West Lafayette-based biotech firm once was seen as a rising star with a pipeline that could save cancer patients. Now, 20 years after its founding, without a single launch, it is laying off 40 percent of its workforce.
    www.ibj.com
  • does the imaging technology have any value.....or did that go with the programs being terminated?
  • this pos seems to have no bottom, it's been almost a week now and it only appears to have a know the way down...just thinkink it was a billion dollar company 3 years ago and now it's worth peanuts...
  • This is a disaster, CEO must announce executive pay cuts. They really need to consider auctioning their technology and liquidating company via special dividend. Cash is reducing daily with no return in sight.